Noreen Brar

Sr. Strategist

2021 - Current

Associate

2020 - 2021

Analyst

2019 - 2020

Investment Principal

2020 - 2021

- Sourced and evaluated startups to assess company fit, led diligence calls, and completed due diligence on 6 startups resulting in investment - Assisted portfolio companies with conceptualizing new marketing tactics and business opportunities within women's health - Led SteelSky Fellows/Internship program managed 30+ students across 3 universities to provide portfolio support

Analyst

2018 - 2019

Patented SPEAR platform removes immunilogical barriers to generate off-the-shelf and organ replacements to avoid long-term medication, repeat transplants and associated patient deaths. • Lead market research on relevant competitors in targeted delivery of diagnostic and therapeutic agents, identify market opportunities, and define current product • Guided product development by conducting thorough investigations into the FDA approval process • Conducted customer interviews, analyzed market penetration points and developed future acquisition strategy

Consultant

2015 - 2019

Targeted delivery of chemotherapy for pancreatic cancer patients • Organized and collected data, to derive insights and provide actionable recommendations for product development • Crafted marketing strategies for targeted doses of chemotherapy to the peripheral vasculature • Designed improved internal processes to reduce on-boarding time for future board members

Undergraduate Student Researcher

2016 - 2018

Under Dr. Annaliese Franz, emphasis on organic chemistry

Undergraduate Researcher

2017 - 2018

Under Dr. Amber Boydstun, emphasis on American Politics